Equities research analysts at Cantor Fitzgerald started coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a research report issued on Wednesday. The brokerage set an “overweight” rating and a $34.00 price target on the real estate investment trust’s stock. Cantor Fitzgerald’s price target suggests a potential upside of 25.46% from the stock’s current price.
The analysts wrote, “Operator issues come with the business. OHI is more exposed to skilled nursing than many of its peers, but challenged operators are not uncommon. We like skilled nursing and OHI’s management has many years of experience in the industry. We believe that skilled nursing is well-positioned as a post-acute provider to capitalize on the growing role of value-based reimbursement, and we believe that OHI’s problems with three operators will be resolved in 2018 as their portfolios are restructured or transitioned.””
A number of other equities analysts also recently commented on the company. Zacks Investment Research downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Friday, November 3rd. Hilliard Lyons downgraded Omega Healthcare Investors to a “buy” rating in a report on Wednesday, November 1st. Vetr downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 target price for the company. in a report on Monday, October 30th. ValuEngine downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Wednesday, September 6th. Finally, Stifel Nicolaus downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and decreased their target price for the company from $35.00 to $29.00 in a report on Tuesday, October 31st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $32.14.
In related news, Director Craig R. Callen bought 10,000 shares of the business’s stock in a transaction dated Thursday, November 2nd. The shares were purchased at an average cost of $27.38 per share, with a total value of $273,800.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bernard J. Korman bought 100,000 shares of the business’s stock in a transaction dated Tuesday, October 31st. The stock was bought at an average cost of $28.24 per share, for a total transaction of $2,824,000.00. Following the completion of the purchase, the director now owns 903,895 shares of the company’s stock, valued at approximately $25,525,994.80. The disclosure for this purchase can be found here. Corporate insiders own 1.54% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the stock. Baltimore Washington Financial Advisors Inc. boosted its position in shares of Omega Healthcare Investors by 5.5% during the third quarter. Baltimore Washington Financial Advisors Inc. now owns 244,212 shares of the real estate investment trust’s stock valued at $7,793,000 after buying an additional 12,690 shares during the last quarter. Pacer Advisors Inc. boosted its position in Omega Healthcare Investors by 17.1% in the second quarter. Pacer Advisors Inc. now owns 28,758 shares of the real estate investment trust’s stock worth $950,000 after purchasing an additional 4,194 shares during the last quarter. First Trust Advisors LP boosted its position in Omega Healthcare Investors by 17.5% in the third quarter. First Trust Advisors LP now owns 533,770 shares of the real estate investment trust’s stock worth $17,033,000 after purchasing an additional 79,562 shares during the last quarter. Honeywell International Inc. boosted its position in Omega Healthcare Investors by 27.8% in the third quarter. Honeywell International Inc. now owns 56,210 shares of the real estate investment trust’s stock worth $1,794,000 after purchasing an additional 12,210 shares during the last quarter. Finally, Jaffetilchin Investment Partners LLC purchased a new position in Omega Healthcare Investors in the third quarter worth about $277,000. 67.95% of the stock is currently owned by institutional investors.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
